Author Archives: Jwalant Swaroop

Happy news for cancer patients globally

With the arrival of two revolutionary treatment strategies, immunotherapy and personalised medicine, cancer researchers have found new hope -and a problem that is perhaps unprecedented in medical research. There are too many experimental cancer drugs in too many clinical trials, and not enough patients to test them on. The logjam is caused partly by companies […]